W
TBI Research Wiki
Retour à la liste des entreprisesSlug: davide-campari-milano-n-v

Davide Campari-Milano N.V.

CPR IMConsumer Staples
Devise: USD
TBI Multi Score0
Scores quantitatifs indisponibles pour cette valeur.

Analyse Graphique (TradingView)

Ticker: CPR

Rapport d'Analyse & Thèse d'Investissement

Davide Campari-Milano N.V.

Business description

A leading premium spirits company with global distribution in over 190 countries, focused primarily on the aperitifs category.

Key financials

  • Net Sales (2025): EUR 3.05 billion
  • A&P to Net Sales Ratio: 17.9%
  • Target Price: EUR 6.50 (12-month)
  • Implied P/E (2026): 19.1x

Competitive moat

Strong dominance in the aperitifs category (Aperol, Campari), which provides a stable foundation but creates high concentration risk.

Recent developments

  • Strategic Pivot: Implemented the "House of Brands" operating model in 2025 to enhance brand planning and innovation.
  • Diversification Efforts: Acquired Courvoisier for USD 1.20 billion in 2024 to expand beyond aperitifs.
  • AI Visibility Struggle: Ranked lowest in GEO visibility tests, indicating an execution gap in converting brand ownership into AI-driven discovery.

Investment risks / red flags

  • Concentration Risk: Heavy reliance on aperitifs for a significant portion of net sales.
  • GEO Lag: Poor visibility in GenAI platforms for its non-aperitif offerings.

H-Score signals

TBI multi factor score: Not available

Theme exposure

[[European Distillers and Vintners]]

Related

[[Pernod Ricard SA]], [[European Distillers and Vintners]]